Cargando…

A sensitive tissue factor activity assay determined by an optimized thrombin generation method

BACKGROUND: Tissue factor (TF) is the principal activator of the coagulation system, but an increased concentration in the blood in cancer and inflammatory diseases has been suggested to play a role increasing the risk of venous thromboembolism. However, measurement of the TF concentration is diffic...

Descripción completa

Detalles Bibliográficos
Autores principales: Kristensen, Søren Risom, Nybo, Jette
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10355404/
https://www.ncbi.nlm.nih.gov/pubmed/37467256
http://dx.doi.org/10.1371/journal.pone.0288918
_version_ 1785075132718383104
author Kristensen, Søren Risom
Nybo, Jette
author_facet Kristensen, Søren Risom
Nybo, Jette
author_sort Kristensen, Søren Risom
collection PubMed
description BACKGROUND: Tissue factor (TF) is the principal activator of the coagulation system, but an increased concentration in the blood in cancer and inflammatory diseases has been suggested to play a role increasing the risk of venous thromboembolism. However, measurement of the TF concentration is difficult, and quantitation of activity is the most valid estimation. The objective of this study was to establish a sensitive method to measure TF activity based on thrombin generation. METHODS: The assay is based on thrombin generation (TG) measured on the Calibrated Automated Thrombogram (CAT). Various low concentrations of TF were prepared from reagents containing 1 pM TF and 4 μM phospholipid (PPL), and no TF and 4 μM PPL, and a calibration curve was produced from Lagtime vs TF concentration. TF in blood samples was measured after isolation and resuspension of extracellular vesicles (EVs) in a standard plasma from which EVs had been removed. The same standard plasma was used for the calibrators. RESULTS: Contact activation of the coagulation system was avoided using CTI plasma samples in Monovette tubes. EVs contain procoagulant phospholipids but addition of PPL only reduced lagtime slightly at very low concentrations of TF resulting in overestimation to a lesser extent at 10 fM but no interference at 30 fM or higher. Addition of EVs to the TG analysis induced a small unspecific TF-independent activity (i.e., an activity not inhibited by antibodies against TF) which also may result in a smaller error in estimation of TF activity at very low levels but the effect was negligible at higher concentrations. It was possible to measure TF activity in healthy controls which was found to be 1–6 fM (EVs were concentrated, i.e. solubilized in a lower volume than the original volume plasma). Coefficient of variation (CV) was below 20% at the low level, and below 10% at a level around 100 fM TF. However, the step with isolation of EVs have a higher inherent CV. CONCLUSION: A sensitive and rather precise one-stage TG-based method to measure TF activity has been established.
format Online
Article
Text
id pubmed-10355404
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-103554042023-07-20 A sensitive tissue factor activity assay determined by an optimized thrombin generation method Kristensen, Søren Risom Nybo, Jette PLoS One Research Article BACKGROUND: Tissue factor (TF) is the principal activator of the coagulation system, but an increased concentration in the blood in cancer and inflammatory diseases has been suggested to play a role increasing the risk of venous thromboembolism. However, measurement of the TF concentration is difficult, and quantitation of activity is the most valid estimation. The objective of this study was to establish a sensitive method to measure TF activity based on thrombin generation. METHODS: The assay is based on thrombin generation (TG) measured on the Calibrated Automated Thrombogram (CAT). Various low concentrations of TF were prepared from reagents containing 1 pM TF and 4 μM phospholipid (PPL), and no TF and 4 μM PPL, and a calibration curve was produced from Lagtime vs TF concentration. TF in blood samples was measured after isolation and resuspension of extracellular vesicles (EVs) in a standard plasma from which EVs had been removed. The same standard plasma was used for the calibrators. RESULTS: Contact activation of the coagulation system was avoided using CTI plasma samples in Monovette tubes. EVs contain procoagulant phospholipids but addition of PPL only reduced lagtime slightly at very low concentrations of TF resulting in overestimation to a lesser extent at 10 fM but no interference at 30 fM or higher. Addition of EVs to the TG analysis induced a small unspecific TF-independent activity (i.e., an activity not inhibited by antibodies against TF) which also may result in a smaller error in estimation of TF activity at very low levels but the effect was negligible at higher concentrations. It was possible to measure TF activity in healthy controls which was found to be 1–6 fM (EVs were concentrated, i.e. solubilized in a lower volume than the original volume plasma). Coefficient of variation (CV) was below 20% at the low level, and below 10% at a level around 100 fM TF. However, the step with isolation of EVs have a higher inherent CV. CONCLUSION: A sensitive and rather precise one-stage TG-based method to measure TF activity has been established. Public Library of Science 2023-07-19 /pmc/articles/PMC10355404/ /pubmed/37467256 http://dx.doi.org/10.1371/journal.pone.0288918 Text en © 2023 Kristensen, Nybo https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Kristensen, Søren Risom
Nybo, Jette
A sensitive tissue factor activity assay determined by an optimized thrombin generation method
title A sensitive tissue factor activity assay determined by an optimized thrombin generation method
title_full A sensitive tissue factor activity assay determined by an optimized thrombin generation method
title_fullStr A sensitive tissue factor activity assay determined by an optimized thrombin generation method
title_full_unstemmed A sensitive tissue factor activity assay determined by an optimized thrombin generation method
title_short A sensitive tissue factor activity assay determined by an optimized thrombin generation method
title_sort sensitive tissue factor activity assay determined by an optimized thrombin generation method
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10355404/
https://www.ncbi.nlm.nih.gov/pubmed/37467256
http://dx.doi.org/10.1371/journal.pone.0288918
work_keys_str_mv AT kristensensørenrisom asensitivetissuefactoractivityassaydeterminedbyanoptimizedthrombingenerationmethod
AT nybojette asensitivetissuefactoractivityassaydeterminedbyanoptimizedthrombingenerationmethod
AT kristensensørenrisom sensitivetissuefactoractivityassaydeterminedbyanoptimizedthrombingenerationmethod
AT nybojette sensitivetissuefactoractivityassaydeterminedbyanoptimizedthrombingenerationmethod